December 14, 2022 · STOCK Act disclosure
Representative Michael T. McCaul (Republican-TX) sold Neurocrine Biosciences, Inc., a stock transaction, valued at $15,001 - $50,000. The trade took place on December 14, 2022 and was disclosed on January 19, 2023 (owner: Spouse). Members of Congress must report such transactions within 45 days under the STOCK Act.